Xiaobin Cui Selected Research

Esophageal Squamous Cell Carcinoma

12/2023	Phospholipase PLCE1 Promotes Transcription and Phosphorylation of MCM7 to Drive Tumor Progression in Esophageal Cancer.
1/2021	An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma.
1/2021	Identification of a PLCE1‑regulated competing endogenous RNA regulatory network for esophageal squamous cell carcinoma.
5/2018	Comprehensive bioinformation analysis of the miRNA of PLCE1 knockdown in esophageal squamous cell carcinoma.
11/2017	Comprehensive bioinformatics analysis of the mRNA profile of PLCE1 knockdown in esophageal squamous cell carcinoma.
8/2017	MicroRNA and target mRNA selection through invasion and cytotoxicity cell modeling and bioinformatics approaches in esophageal squamous cell carcinoma.
7/2017	Tumor suppressor microRNA-34a inhibits cell migration and invasion by targeting MMP-2/MMP-9/FNDC3B in esophageal squamous cell carcinoma.
1/2016	p53 expression but not p16(INK4A) correlates with human papillomavirus-associated esophageal squamous cell carcinoma in Kazakh population.
5/2015	ORAOV1 overexpression in esophageal squamous cell carcinoma and esophageal dysplasia: a possible biomarker of progression and poor prognosis in esophageal carcinoma.
1/2015	Genetic variation in miR-100 rs1834306 is associated with decreased risk for esophageal squamous cell carcinoma in Kazakh patients in northwest China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaobin Cui Research Topics

Disease

25	Neoplasms (Cancer) 12/2023 - 01/2014
10	Esophageal Squamous Cell Carcinoma 12/2023 - 01/2015
6	Esophageal Neoplasms (Esophageal Cancer) 12/2023 - 04/2014
6	Carcinogenesis 01/2021 - 01/2014
3	Carcinoma (Carcinomatosis) 03/2020 - 05/2015
2	Inflammation (Inflammations) 03/2024 - 11/2017
2	Synovial Sarcoma (Synovioma) 10/2019 - 01/2017
1	Squamous Cell Carcinoma of Head and Neck 10/2022
1	Colonic Neoplasms (Colon Cancer) 12/2020
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Breast Neoplasms (Breast Cancer) 02/2019
1	Disease Progression 01/2019
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2016
1	Lymphatic Metastasis 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2016
1	Infections 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Rhabdomyosarcoma 01/2014

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 10/2022 - 05/2015
8	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2015
6	phospholipase C epsilonIBA 12/2023 - 04/2014
4	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2014
4	ParaffinIBA 10/2019 - 01/2014
3	Formaldehyde (Formol)FDA Link 01/2019 - 01/2014
3	VimentinIBA 01/2015 - 01/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2017
2	3-hydroxy-5-estrane-17-carbonitrile (ACN)IBA 01/2019 - 10/2014
2	Messenger RNA (mRNA)IBA 11/2017 - 08/2017
1	triptolideIBA 03/2024
1	Phospholipases (Phospholipase)IBA 12/2023
1	Trastuzumab (Herceptin)FDA Link 01/2023
1	Type C PhospholipasesIBA 10/2022
1	Biotin (Vitamin H)FDA Link 01/2022
1	Competitive Endogenous RNAIBA 01/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2020
1	OsteopontinIBA 03/2020
1	Fibronectins (Fibronectin)IBA 03/2020
1	Carrier Proteins (Binding Protein)IBA 10/2019
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 10/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2019
1	Betulinic AcidIBA 02/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	Vascular Endothelial Growth Factor CIBA 01/2019
1	ChemokinesIBA 11/2017
1	LigandsIBA 11/2017
1	Matrix Metalloproteinases (MMPs)IBA 07/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2016
1	transporter associated with antigen processing (TAP)IBA 07/2015
1	HLA-DRB1 Chains (HLA DRB1)IBA 10/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 10/2014
1	HLA-DQB1 antigen (HLA DQB1)IBA 10/2014
1	EpitopesIBA 10/2014
1	CalponinsIBA 01/2014
1	MART-1 AntigenIBA 01/2014
1	AntigensIBA 01/2014
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2014
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2014
1	Collagen Type IV (Type IV Collagen)IBA 01/2014

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2022
1	Photothermal Therapy 01/2022
1	Immunotherapy 01/2021